Big Move For Forty Seven, Inc.
Mon, Mar 02, 2020 at 05:30 PM
Forty Seven, Inc. (FTSV:NASDAQ) rocketted at $93.91, a gain of 61.9%. On Fri 28 Feb 20, FTSV:NASDAQ hit a New 2-Week High of $58. The stock appeared on our News Catalysts scanner on Mon 02 Mar 20 at 08:33 AM in the 'BIOTECH' category. From Fri 07 Feb 20, the stock recorded 71.43% Up Days and 66.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Forty Seven, Inc. (FTSV:NASDAQ)
Forty Seven Inc is a clinical-stage immuno-oncology company. It is engaged in developing novel checkpoint therapies to activate macrophages and help the patients in their fight against cancer.
Top 10 Gainers:
- Heat Biologics, Inc. (HTBX:NASDAQ), 142.42%
- Novan, Inc. (NOVN:NASDAQ), 112.51%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 100%
- BioPharmX Corporation (BPMX:NYSEMKT), 78.38%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 69.65%
- Daxor Corporation (DXR:NYSEMKT), 65.7%
- Forty Seven, Inc. (FTSV:NASDAQ), 61.91%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 55.83%
- NuCana plc (NCNA:NASDAQ), 45.74%
- InflaRx N.V. (IFRX:NASDAQ), 43.4%